Ivabradine Impurity 75 | CAS 2253977-83-0 - Request Quote
Ivabradine Impurity 75
| SZ CAT No: | SZ-I014106 |
| CAS No | 2253977-83-0 |
| Mol.F. | C12H13NO4 |
| Mol.Wt. | 235.2 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ivabradine Impurity 75 is chemically 7,8-Dimethoxy-2,3-dihydro-1H-benzo[d]azepine-1,4(5H)-dione. Ivabradine Impurity 75 is supplied with detailed characterization data compliant with regulatory guideline. Ivabradine Impurity 75 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ivabradine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2253977-83-0
Purchase 2253977-83-0
Order 2253977-83-0
Enquire 2253977-83-0
price of 2253977-83-0
2253977-83-0 Supplier
2253977-83-0 Manufacturer
2253977-83-0 Exporter
buy high quality Ivabradine Impurity 75
Purchase Ivabradine Impurity 75
Ivabradine Impurity 75 suppliers
Ivabradine Impurity 75 manufacturers
Ivabradine Impurity 75 price
Order Ivabradine Impurity 75
Enquire Ivabradine Impurity 75
Ivabradine Impurity 75 cost
Ivabradine Impurity 75 Supplier
Ivabradine Impurity 75 Distributor
Ivabradine Impurity 75 for Method Validation
Ivabradine Reference Standard
Ivabradine Impurity 75 for ANDA Filing
Ivabradine Impurity 75 for Forced Degradation Studies
Ivabradine Impurity 75 Identification Standards
Ivabradine Impurity 75 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


